Publicacions en col·laboració amb investigadors/es de Oxford Brookes University (8)

2008

  1. Aliskiren - The first of a new class of antihypertensive

    Drugs in Context, Vol. 4, Núm. 1, pp. 105-120

  2. Cervarix - Preventing cervical cancer and other diseases related to HPV

    Drugs in Context, Vol. 4, Núm. 1, pp. 59-70

  3. Coversyl Plus - Treating hypertension and improving clinical outcomes in T2D and other high risk groups

    Drugs in Context, Vol. 4, Núm. 1, pp. 71-84

  4. Ezetimibe - A clinically effective and a cost-effective treatment option for dyslipidaemia

    Drugs in Context, Vol. 4, Núm. 1, pp. 85-104

  5. Gardasil - Preventing cervical cancer and other diseases related to HPV

    Drugs in Context, Vol. 4, Núm. 1, pp. 29-40

  6. Inegy - Effective combination treatment to target LDL-C levels

    Drugs in Context, Vol. 4, Núm. 1, pp. 41-58

  7. Telmisartan - An effective antihypertensive for 24-hour blood pressure control

    Drugs in Context, Vol. 4, Núm. 1, pp. 1-14

  8. Tiotropium - Advancing the treatment of COPD

    Drugs in Context, Vol. 4, Núm. 1, pp. 15-28